Gene · 8764
Papers3,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Tumor Antigens and Immune Subtypes of High-grade Serous Ovarian Cancer for mRNA Vaccine Development. | J Cancer | 2023 | 37779866 | PubTator, text mining | PubMed |
| Plasma tumour necrosis factor-alpha-related proteins in prognosis of heart failure with pulmonary hypertension. | ESC Heart Fail | 2023 | 37772417 | PubTator, text mining | PubMed |
| A novel signature for predicting prognosis and immune landscape in cutaneous melanoma based on anoikis-related long non-coding RNAs. | Sci Rep | 2023 | 37770477 | PubTator, text mining | PubMed |
| When Bacteria and Viruses Collide: A Tale of Chlamydia trachomatis and Sexually Transmitted Viruses. | Viruses | 2023 | 37766360 | PubTator, text mining | PubMed |
| Exploring the Complex and Multifaceted Interplay between Melanoma Cells and the Tumor Microenvironment. | Int J Mol Sci | 2023 | 37762707 | PubTator, text mining | PubMed |
| Single-Cell RNA-Sequencing Reveals Peripheral T Helper Cells Promoting the Development of IgG4-Related Disease by Enhancing B Cell Activation and Differentiation. | Int J Mol Sci | 2023 | 37762039 | PubTator, text mining | PubMed |
| Sex Differences in the Efficacy of Immune Checkpoint Inhibitors in Neoadjuvant Therapy of Non-Small Cell Lung Cancer: A Meta-Analysis. | Cancers (Basel) | 2023 | 37760403 | PubTator, text mining | PubMed |
| [Chinese guidelines for diagnosis and treatment of follicular lymphoma(2023)]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 37749030 | PubTator, text mining | PubMed |
| Expression of HPV-16 E6 and E7 oncoproteins alters Chlamydia trachomatis developmental cycle and induces increased levels of immune regulatory molecules. | Front Cell Infect Microbiol | 2023 | 37743859 | PubTator, text mining | PubMed |
| Dry blood spot samples to monitor immune-associated mRNA expression in intervention studies: Impact of Baker's yeast beta glucan. | Methods | 2023 | 37741562 | PubTator, text mining | PubMed |
| A critical review on antiviral peptides derived from viral glycoproteins and host receptors to decoy herpes simplex virus. | Microb Biotechnol | 2023 | 37740682 | PubTator, text mining | PubMed |
| Binding of herpesvirus entry mediator (HVEM) and HSV-1 gD affect reactivation but not latency levels. | PLoS Pathog | 2023 | 37738264 | PubTator, text mining | PubMed |
| ANXA1 is identified as a key gene associated with high risk and T cell infiltration in primary sclerosing cholangitis. | Hum Genomics | 2023 | 37735492 | PubTator, text mining | PubMed |
| Identification of a TRP channel-related risk model for predicting prognosis and therapeutic effects of patients with hepatocellular carcinoma. | J Cancer Res Clin Oncol | 2023 | 37733242 | PubTator, text mining | PubMed |
| Variation in the gene encoding the co-inhibitory molecule BTLA is associated with survival in patients treated for clear cell renal carcinoma - results of a prospective cohort study. | Arch Med Sci | 2023 | 37732048 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing shows the immune cell landscape in the kidneys of patients with idiopathic membranous nephropathy. | Front Immunol | 2023 | 37731504 | PubTator, text mining | PubMed |
| Spatial transcriptomics delineates molecular features and cellular plasticity in lung adenocarcinoma progression. | Cell Discov | 2023 | 37723144 | PubTator, text mining | PubMed |
| Pan-cancer analysis of kinesin family members with potential implications in prognosis and immunological role in human cancer. | Front Oncol | 2023 | 37711200 | PubTator, text mining | PubMed |
| Differences in mutational signature of diffuse large B-cell lymphomas according to the primary organ. | Cancer Med | 2023 | 37706649 | PubTator, text mining | PubMed |
| Portraying the dark side of endogenous IFN-λ for promoting cancer progression and immunoevasion in pan-cancer. | J Transl Med | 2023 | 37697300 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8764/papers?page=20